Fresenius in talks to acquire US-based Akorn

13 April 2017 - Deborah Wilkes

Archived

German healthcare company Fresenius is in talks to acquire US generics, OTC and animal health company Akorn.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: